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A B S T R A C T
Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular condition of childhood and is clin-
icopathologically related to tufted angioma (TA), a benign skin lesion.
Due to their rarity molecular data are scarce.
We investigated 7 KHE and 3 TA by comprehensive mutational analysis and genome-wide methylation
profiling and compared the clustering, also with vascular malformations.
Lesions were from 7 females and 3 males. The age range was 2 months to 9 years with a median of 10 months.
KHEs arose in the soft tissue of the thigh (n = 2), retroperitoneum (n = 1), thoracal/abdominal (n = 1), su-
praclavicular (n = 1) and neck (n = 1). One patient presented with multiple lesions without further in-
formation. Two patients developed a Kasabach-Merritt phenomenon. TAs originated in the skin of the shoulder
(n = 2) and nose/forehead (n = 1).
Of the 5 KHEs and 2 TAs investigated by DNA sequencing, one TA showed a hot spot mutation in NRAS, and
one KHE a mutation in RAD50.
Unsupervised hierarchical clustering analysis indicated a common methylation pattern of KHEs and TAs,
which separated from the homogeneous methylation pattern of vascular malformations.
In conclusion, methylation profiling provides further evidence for KHEs and TAs potentially forming a
spectrum of one entity. Using next generation sequencing, heterogeneous mutations were found in a subset of
cases (2/7) without the presence of GNA14 mutations, previously reported in KHE and TA.
Original Contribution
1. Introduction
The term kaposiform hemangioendothelioma (KHE) was introduced
by Zukerberg et al. in 1993 for a vascular tumor with locally aggressive
behavior and morphological features similar to Kaposi sarcoma [1].
These lesions mainly occur in (early) childhood but also have been
infrequently reported in (young) adults. Tumors may arise in super-
ficially or deep soft tissue and are mainly located in the extremities.
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Other localizations are the trunk, retroperitoneum, head and neck,
mediastinum and visceral organs as thymus and spleen [1,2]. Kasabach-
Merritt-phenomenon or disseminated intravascular coagulation with
thrombopenia and anemia are adverse clinical conditions often asso-
ciated with a deep anatomic site [1-8].
One of the intriguing morphological features previously described is
the presence of large lymphatic vessels, called lymphangiomatosis
showing resemblance to vascular malformations [1,2,4,5]. Therefore, it
seemed worthwhile to investigate, whether there is a possible link with
vascular malformations.
Tufted angioma (TA) is discussed to be the dermal counterpart of
KHE with a benign clinical course due to the superficial origin [2,4,5-
7].
From the recent clinical point of view, treatment with sirolimus has
been shown successful in KHE and therefore a biopsy for diagnostic
purposes would influence treatment decisions. However clinical and
morphological diagnosis can be challenging and diagnostically sup-
portive molecular data are not established [2,8].
We analyzed FFPE material from KHE cases (n = 7) and tufted
angiomas (n = 3) using comprehensive mutational analysis and
genome-wide methylation profiling and compared the data with those
of vascular malformations (n = 14).
2. Material and methods
The cases were retrieved from the authors' (referral) files using the
WHO criteria [9]. Clinical details were obtained from the referring
physicians. The study was conducted in accordance with the Code of
Conduct of the Federation of Medical Scientific Societies of Germany
and the Netherlands.
In all cases the tissue was fixed in 4% buffered formalin, routinely
processed and embedded in paraffin; 2–4 μm thick sections were
stained with hematoxylin and eosin.
Immunohistochemistry was performed using standard procedures
and the following primary antibodies, ERG (EPR3864, 1:2000, ABCam,
Cambridge, UK), CD31 (JC70 A, 1:100, DAKO, Glostrup, Denmark),
CD34 (My10, 1:100, BD Biosciences, Heidelberg, Germany), D2–40
(D2–40, 1:100, DAKO, Glostrup, Denmark), GLUT1 (SPM498, 1:400,
Zytomed Systems, Berlin, Germany), WT1 (6F–H2, 1:400, DAKO,
Glostrup Denmark)
2.1. DNA isolation, genome-wide DNA methylation data generation and
pre-processing
Representative tumor tissue with highest available tumor content
was chosen for DNA extraction. The Maxwell® 16 FFPE Plus LEV DNA
Kit or the Maxwell® 16 Tissue DNA Purification Kit (for frozen tissue)
was applied on the automated Maxwell device (Promega, Madison, WI,
USA) according to the manufacturer's instructions. All tumors had a
total amount of> 100 ng DNA and were suitable for the array-based
DNA methylation analysis. All tumors were subjected to Illumina
Infinium HumanMethylation450 (450 k) BeadChip or the successor
EPIC/850 k BeadChip (Illumina, San Diego, USA) analysis at the
Genomics and Proteomics Core Facility of the German Cancer Research
Center (DKFZ) Heidelberg. DNA methylation data were normalized by
performing background correction and dye bias correction (shifting of
negative control probe mean intensity to zero and scaling of normal-
ization control probe mean intensity to 20,000, respectively). Probes
targeting sex chromosomes, probes containing multiple single nucleo-
tide polymorphisms and those that could not be uniquely mapped were
removed. Probes from the EPIC array were excluded if the predecessor
Illumina Infinium 450 k BeadChip did not cover them, thereby making
data generated by both 450 k and EPIC feasible for subsequent analyses.
In total, 438,370 probes were kept for analysis.
Table 1
Diagnoses and clinical features.
# Diagnosis Sex/age Site and clinical features Follow-up
1 KHE m/8 mo Intrathoracal/intraabdominal NA
2 KHE m/6 mo NA, multiple lesions NA
3 KHE f/5 mo Supraclavicular, KMP NA
4 KHE m/2 mo Neck, intramuscular NA
5 KHE f/12 mo Thigh, deep NA
6 KHE f/4 mo Thigh, skin, soft tissue, inoperable NA
7 KHE f/15 mo Retroperitoneum, KMP DOD, 1 mo
8 TH f/15 mo Shoulder CE
9 TH f/18 mo Shoulder, multiple lesions CE
10 TH f/9 y Nose/forehead NA
KHE, kaposiform hemangioendothelioma; TA, tufted angioma; m, male; f, fe-
male; mo, months; y, years; KMP, Kasabach-Merritt phenomenon; NA, not
analyzed; CE, complete excision; DOD, dead of disease.
Fig. 1. KHE, consisting of vasoformative plump spindle cells with mono-
morphic elongated nuclei arranged in coalescing nodules. Note the larger vas-
cular malformation-like vessels in the surrounding (Case 1).
Fig. 2. TA showing the typical “cannonball structures” and diffuse growing
subtle vascular channels (Case 8).
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2.2. Unsupervised clustering, t-SNE analysis and cumulative copy number
plotting
For unsupervised hierarchical clustering, we selected 10,000 probes
that showed the highest median absolute deviation (MAD) across the
beta values. Samples were hierarchically clustered using the Euclidean
distance and Ward's linkage method. Hierarchical clustering using
Euclidean distance and complete linkage reordered methylation probes.
The unscaled methylation levels were shown in a heat map from un-
methylated state (blue color) to methylated state (red color). For un-
supervised 2D representation of pairwise sample correlations, di-
mensionality reduction by t distributed stochastic neighbor embedding
(t-SNE) was performed using the 10,000 most variable probes, a per-




1 KHE No mutation
2 KHE No mutation
3 KHE Not analyzed
4 KHE No mutation
5 KHE No mutation
6 KHE Not analyzed
7 KHE RAD50, R1185X
8 TA NRAS, Q61H
9 TA Not analyzed







































































































































Fig. 3. Unsupervised hierarchical clustering of methylation shows a similar profile of TA and KHE demonstrating that these lesions are epigenetically related in
contrast to vascular malformations, which cluster apart.
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for stability by varying the number of the most variable probes.
2.3. Next generation DNA sequencing
Next generation DNA sequencing was performed as described by
Sahm et al. 2016 and ten Broek et al. 2019 [10,11].
3. Results
KHEs (n = 7) and TAs (n = 3) were from seven females and three
males. The age range was 2 months to 9 years with a median of
10 months. KHEs arose in the thigh (n = 2), retroperitoneum (n = 1),
thoracal/abdominal (n = 1), supraclavicular (n= 1) and neck (n = 1).
One patient presented with multiple lesions but there was no in-
formation about their sites. Patients #3 and 7 developed a Kasabach-
Merritt phenomenon. The lesions diagnosed as TA originated in the skin
of the shoulder (n = 2) and nose/forehead (n = 1). One of the TAs of
the shoulder was multifocal (Table 1).
Histomorphologically, KHEs showed infiltrative growing irregular
nodules surrounded by desmoplastic stroma. The nodules consisted of
vasoformative spindle cells with variable convoluting and slit-like small
lumina. Sometimes lumina were very subtle. The endothelial cells
possessed monomorphic enlongated and tapered nuclei (Fig. 1). Small
areas depicted a more epithelioid aspect. Lymphatics in variable sizes
were scattered throughout. The TAs showed prominent cannonball
structures accompanied by lymphatic vessels in the surrounding. In one
case also a diffuse growing spindle cell component was obvious (Fig. 2).
The nuclei were not different from KHE cases.
Using immunohistochemistry, all analyzed lesions were positive for
CD31 (9/9), CD34 (7/7) and ERG (1/1). Patchy positivity of D2–40 was
seen in 6/6 KHEs and in one tested TA. In two KHEs GLUT1 was focally
expressed and in one investigated KHE case, WT1 was partly absent.
Data of the comprehensive mutational analysis were shown in
Table 2.
One TA harbored a mutation in NRAS (p.Q61H) and one KHE a
stopgain mutation in RAD50 (pR1185X).
3.1. Genome-wide methylation analysis
KHEs (n= 5) and TAs (n= 2) formed a homogeneous methylation
cluster both by unsupervised hierarchical clustering and by t-SNE
analysis, which kept stable when varying the number of CpGs (Fig. 3).
Fourteen vascular malformations formed a separate cluster (Fig. 3).
Their clinical, histopathological and molecular data are depicted in
Table 3.
4. Discussion
The molecular understanding of vascular neoplasms is steadily
growing. However KHE and TA are poorly understood. To the best of
our knowledge, we here present for the first time epigenetic data on
these rare tumors and provide further evidence that KHE and TA share a
common origin without a relationship to vascular malformation.
A genetic based study has found GNA14 mutations in KHE and TA
[12]. However, these mutations are not entity specific since they are
also described in other vascular lesions like lobular capillary he-
mangioma, congenital hemangioma, anastomosing hemangioma and
hepatic small vessel neoplasm [12-14], which are potential differential
diagnoses [2].
In our series (n = 7) we were not able to find GNA14 mutations.
Instead, comprehensive mutational analysis showed a mutation in
NRAS in one TA, and RAD50 in one KHE.
The proto-oncogen NRAS encodes a small GTPase regulating cell
proliferation. Mutations in NRAS stimulate the RAS-RAF-MEK-ERK
signaling pathway and were also identified in vascular malformations
[11]. Recently, recurrent NRAS hot spot mutations have been reported
in kaposiform lymphangiomatosis (KLA) [[15]]. One could argue that
KLA and KHE are related lesions and indeed there are overlapping
clinicopathological features, including Kasabach-Merritt phenomenon.
However, in contrast to a local process of KHE in most of the cases,
KLAs are reported often as multifocal lesions with involvement of the
thoracic cavity, retroperitoneum, bone, spleen and soft tissue. Mor-
phologically, both lesions show spindled endothelial cells and abnormal
lymphatic channels. It seems that the spindle cell component of KLA is
frequently arranged in parallel fashion, poorly marginated clusters and
anastomosing strands/sheets, whereas KHEs grow in confluent nodules
with glomeruloid features. Overall, similarities of these entities are
remarkable [16].
Our NRAS mutated case was a tufted hemangioma with typical
cannonball structures and a diffuse growing component consisting of
spindled endothelial cells suggesting that KHE, KLA and TA are related.
RAD50, mutated in one of the KHE cases of our series, belongs to the
ABC transporter family of ATPases and is normally involved in DNA
double-strand break repair, cell cycle checkpoint activation, telomerase
maintenance, and meiotic recombination. Mouse knockout studies
suggest an essential role in growth and viability [17-19].
The epigenetic genome-wide methylation profile showed simila-
rities between tufted angioma and KHE congruent with the morpholo-
gical features supporting that these lesions are strongly related.
However, this group is clustered apart from vascular malformations
demonstrating that there may be no relationship despite overlapping
mutations and the presence of abnormal lymphatic channels in KHE
Table 3
Histological, clinical and molecular features of the included vascular malformations.
# Sex/age (y) Site Clinical features Histology Mutations
1 m/53 Dura Atypical vascular lesion Capillary malformation GNAQ: c.627A>C (p.(Gln209His)) and
PIK3CA: c.3140A>G (p.(His1047Arg))
2 f/45 Arm KTS spectrum with port wine stain Venous malformation KRAS: c.436G>A (p.(Ala146Thr))
3 f/81 Lower lip port wine stain in SWS Combined malformation GNAQ: c.548G>A (p.(Arg183Gln))
4 m/76 Lower leg AVM with ulceration AVM KRAS: c.34G>T (p.(Gly12Cys))
5 f/70 Buttock subcutis unknown Veno-capillary malformation KRAS: c.35G>A (p.(Gly12Asp))
6 m/15 Skin (clavicula) non congenital high flow lesion Veno-capillary malformation GNAQ: c.626A>T (p.(Gln209Leu))
7 m/41 Flank lipoma-like lesion Venous malformation KRAS: c.35G>C (p.(Gly12Ala))
8 f/56 Flank vascularized tumor Veno-capillary malformation KRAS: c.35_38delinsCTCA
(p.(Gly12_Gly13delinsAlaHis))
9 f/20 Muscle Unknown Combined vascular malformation not identified
10 f/64 Epidural Epidural mass Veno-capillary malformation GNAQ: c.627A>C (p.(Gln209His))
11 f/43 Upper lip KTS spectrum with port wine stain; Venous malformation GNAQ: c.548G>A (p.(Arg183Gln))
12 m/12 Skin (thorax) multiple eruptive vascular lesions Capillary malformation NRAS: c.182A>G (p.(Gln61Arg))
13 m/32 Cheek KTS spectrum with lymphedema Venous malformation KRAS: c.64C>A (p.(Gln22Lys))
14 f/10 Foot, bladder wall KTS/PROS Combined vascular malformation PIK3CA: c.1633G>A (p.(Glu545Lys))
M, male; f, female; KTS, Klippel-Trenauney Syndrome, PROS, PIK3CA-related overgrowth spectrum.
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and TA. Of note, similar treatment effect of sirolimus in KHE and vas-
cular malformations has been reported, possibly implying that over-
lapping pathways are activated [20-22].
In conclusion, the largely similar epigenetic profiles of KHE and TA
confirm that these lesions are related clustering apart from vascular
malformations. However, the genetic features of KHE and TA seem to
be heterogeneous and need to be further explored. Whether KHE and
KLA are a spectrum of one entity will be another object of investigation.
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